RATIO-TOPISALIC LOTION

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE); SALICYLIC ACID

可用日期:

TEVA CANADA LIMITED

ATC代码:

D07XC01

INN（国际名称）:

BETAMETHASONE

剂量:

0.5MG; 20MG

药物剂型:

LOTION

组成:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5MG; SALICYLIC ACID 20MG

给药途径:

TOPICAL

每包单位数:

30ML/60ML

处方类型:

Prescription

治疗领域:

ANTI-INFLAMMATORY AGENTS

產品總結:

Active ingredient group (AIG) number: 0215695003; AHFS:

授权状态:

APPROVED

授权日期:

2013-02-22

产品特点

_ _
_ratio-TOPISALIC Lotion (Betamethasone Dipropionate and Salicylic
Acid) _
_ _
_Page 1 of 20_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
RATIO-TOPISALIC
Betamethasone Dipropionate (0.5 mg / g as base)
and Salicylic Acid (20 mg / g)
LOTION
TOPICAL CORTICOSTEROID AND KERATOLYTIC
TEVA CANADA LIMITED
Date of Revision:
30 Novopharm Court
April 17, 2020
Toronto, Ontario,
Canada M1B 2K9
www.tevacanada.com
Submission Control No: 235690
_ _
_ratio-TOPISALIC Lotion (Betamethasone Dipropionate and Salicylic
Acid) _
_ _
_Page 2 of 20_
TABLE OF CONTENTS
TABLE OF CONTENTS
.............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
1
INDICATIONS
.................................................................................................................
3
1.1
Pediatrics
...................................................................................................................
3
1.2
Geriatrics
...................................................................................................................
3
2
CONTRAINDICATIONS
................................................................................................
3
3
DOSAGE AND ADMINISTRATION
............................................................................
3
3.1
Dosing Considerations
..............................................................................................
3
3.2
Recommended Dose and Dosage Adjustment
.......................................................... 4
4
MISSED DOSE
.................................................................................................................
4
5
OVERDOSAGE
................................................................................................................
4
6
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING .............. 4
7
WARNINGS AND PRECAUTIONS
..............................................